Allele-specific analysis of cell fusion-mediated pluripotent reprograming reveals distinct and predictive susceptibilities of human X-linked genes to reactivation by Cantone, I et al.
RESEARCH Open Access
Allele-specific analysis of cell fusion-
mediated pluripotent reprograming reveals
distinct and predictive susceptibilities of
human X-linked genes to reactivation
Irene Cantone1*, Gopuraja Dharmalingam2, Yi-Wah Chan1, Anne-Celine Kohler1, Boris Lenhard3,
Matthias Merkenschlager1 and Amanda G. Fisher1*
Abstract
Background: Inactivation of one X chromosome is established early in female mammalian development and can
be reversed in vivo and in vitro when pluripotency factors are re-expressed. The extent of reactivation along the
inactive X chromosome (Xi) and the determinants of locus susceptibility are, however, poorly understood. Here
we use cell fusion-mediated pluripotent reprograming to study human Xi reactivation and allele-specific single
nucleotide polymorphisms (SNPs) to identify reactivated loci.
Results: We show that a subset of human Xi genes is rapidly reactivated upon re-expression of the pluripotency
network. These genes lie within the most evolutionary recent segments of the human X chromosome that are
depleted of LINE1 and enriched for SINE elements, predicted to impair XIST spreading. Interestingly, this cadre
of genes displays stochastic Xi expression in human fibroblasts ahead of reprograming. This stochastic variability
is evident between clones, by RNA-sequencing, and at the single-cell level, by RNA-FISH, and is not attributable
to differences in repressive histone H3K9me3 or H3K27me3 levels. Treatment with the DNA demethylating agent
5-deoxy-azacytidine does not increase Xi expression ahead of reprograming, but instead reveals a second cadre of
genes that only become susceptible to reactivation upon induction of pluripotency.
Conclusions: Collectively, these data not only underscore the multiple pathways that contribute to maintaining
silencing along the human Xi chromosome but also suggest that transcriptional stochasticity among human cells
could be useful for predicting and engineering epigenetic strategies to achieve locus-specific or domain-specific
human Xi gene reactivation.
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Background
In mammals, one of the two female X chromosomes is
randomly inactivated to compensate gene expression
between males (XY) and females (XX) [1]. This
process takes place in the pluripotent cells of the
early embryo and is inherited thereafter through cell
division. As a consequence, female tissues comprise a
mosaic of cells with reciprocal X chromosome
inactivation (XCI) patterns that have been clonally
inherited through development [2].
Silencing along the inactive X chromosome (Xi) leads
to the formation of a condensed nuclear compartment,
which excludes RNA polymerase and is enriched of re-
pressive chromatin modifications (reviewed in [3]). Xist
long non-coding RNA triggers the formation of this
compartment by binding along the Xi [4] and then
recruiting chromatin modifiers such as polycomb repres-
sive complexes [5, 6]. Following these early events, gene
silencing is established and spreads along the Xi with
different kinetics [7–9]. Not all the genes on the Xi are
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effectively silenced and some genes escape inactivation
and instead remain transcriptionally active [10, 11]. The
heterogeneity in kinetics and efficiency of silencing sug-
gests that local genetic and epigenetic features might
determine the susceptibility of X-linked loci to inactiva-
tion. This hypothesis is supported by recent studies
showing that the pre-existing chromatin context favours
the recruitment of different sets of silencing factors and
influences the efficiency with which XCI is established
and propagated [12, 13]. Whether the local gene context
also affects the maintenance of silencing and, therefore,
the susceptibility of gene loci to be reactivated has been
more difficult to interrogate.
The cell type, age and developmental context might
also influence locus susceptibility to silencing and reacti-
vation. Supporting this idea, recent studies in different
mouse cell-types and tissues showed that some Xi genes
escape silencing in a tissue-specific manner [14].
Furthermore, in mouse it has been shown that some
genes escape silencing at the onset of XCI [15], whereas
others are initially silenced in the embryo and are then
reactivated later in development [16]. As genes that es-
cape XCI lack Xist coating [8] and repressive H3K27me3
and H3K9me3 histone modifications [17, 18], one ex-
planation could be that they retain an accessible chro-
matin during XCI and therefore are susceptible to
subsequent reactivation. Supporting this hypothesis,
RNA polymerase II has been shown to bind a subset
of Xi genes that are silenced in some cell lines but
active in others, possibly marking genes permissive to
transcription [19].
Dynamic studies of the global Xi status during cell fate
reprograming offer an opportunity to dissect the influ-
ence of pre-existing chromatin and cellular environ-
ments on Xi gene reactivation. Towards this aim, we
examined Xi-specific expression during pluripotent
reprograming of human female fibroblasts. XCI in
humans has some intrinsic advantages for studying the
impact of gene context and cellular environment on
silencing or transcription. First, the percentage of genes
escaping silencing in human is higher than in mouse
(15% versus 3–7% of mouse), with 10% of genes showing
a variable XCI status (i.e. escape or are subject to silen-
cing) in different females or tissues [20]. This suggests
that spreading of XCI in human might be less efficient
and has evolved independently from different mamma-
lian species. Second, compartmentalisation of the human
X chromosome based on evolutionary, genomic and
chromatin features has revealed some important associa-
tions between locus context and probability of silencing
or escape. For example, many genes escaping XCI are
contained within the evolutionary recent X Added
Region (XAR) enriched for Alu repeats and depleted
of Long Interspersed Elements (LINE) L1 and
H3K27me3/H3K9me3 repressive histone modifications
[17, 18, 21–25]. These findings may implicate a role
for DNA elements, chromatin features and chromo-
somal domains in the spreading of human XCI.
Pluripotent reprograming approaches allow reprodu-
cible studies of Xi reactivation [26] and offer the possi-
bility of investigating the predisposition of different loci.
Interestingly, several studies in human induced pluripo-
tent stem cells (iPSCs) have shown that the Xi can be
either fully or partially reactivated in different clones
[27–29]. A comparative analysis of the X:autosome
expression ratio in several iPSC lines suggested that telo-
meric chromosome regions distal from XIST locus are
preferentially reactivated [28]. However, a general con-
sensus about the susceptibility of genes to X chromo-
some reactivation (XCR) and their location has not been
achieved, mainly due to the variable outcomes of human
iPSC reprograming and a paucity of studies that directly
assess the expression of Xi-specific alleles across the
entire X chromosome. Here, we used RNA-sequencing
(RNA-seq) and allele-specific analyses to investigate hu-
man XCR during pluripotent reprograming of single-cell
derived female fibroblast clones. Because XCR is a late
event in iPSC-reprograming, is unstable and varies de-
pending on the combination of inducing pluripotency
factors and culture conditions (reviewed in [30]), we
have used an alternative model system in which human
fibroblasts (hFs) are reprogrammed by cell-fusion with
mouse embryonic stem cells (mESCs). We have previ-
ously shown that interspecies cell fusions rapidly induce
human pluripotency genes, giving us an opportunity to
access the earliest events and the kinetics of the transi-
tion from the somatic to the pluripotent state [31, 32].
In this study, we determined the expression of human
Xi genes in isogenic female fibroblast clones with differ-
ent active/inactive X chromosomes ahead of and after
cell fusion-mediated reprograming. We showed that a
subset of genes (10% of those identified) is rapidly and
consistently reactivated upon the induction of the
human pluripotency gene network. Importantly, this
group of genes were also shown to display variable
Xi-allelic expression among individual hFs and be-
tween different single-cell derived clones, highlighting
an intrinsic susceptibility to be expressed from the Xi.
Results
SNP detection by RNA-seq of female fibroblast clones
discriminate the Xi and Xa chromosomes
In order to investigate the global expression from the
active (Xa) X chromosomes and Xi, we used RNA-seq
and single-cell derived clones. Clonal selection allows
homogeneous cell lines to be derived with either one
(X1) or the other (X2) inactive chromosome (X1aX2i or
X1iX2a, as illustrated in Fig. 1a). To discriminate
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between the two X chromosomes, we used a hF cell line
with a known single nucleotide polymorphism (SNP) in
the X-linked PDHA1 gene [33] and immortalised cells
by exogenously expressing TERT in order to derive
single-cell clones. Analysis of PDHA1 gene expression
using SNP-specific Taqman probes confirmed reciprocal
Xa/Xi patterns within four isogenic hF clones (X1aX2i in
clones 11 and 12, X1iX2a in clones 27 and 34, Fig. 1b).
Extending the same principle to all X-linked genes, we
reasoned that we could identify heterozygous SNPs by
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Fig. 1 Allele-specific expression in single cell-derived clones discriminates the Xa and Xi. a Scheme illustrates the experimental design. Single cells
that express/silence reciprocal X chromosomes (i.e. X1aX2i or X1iX2a) were isolated from a female (X1X2) hF line with balanced XCI (i.e. NHDF17914)
and expanded to derive reciprocal isogenic clones (e.g. clone 12 and 34). Expression analysis of heterozygous SNPs within X-linked genes then
allowed the active (Xa, open white circle) and inactive (Xi, closed black circle) X chromosomes in each clone to be distinguished. b Plot showing
allele-specific expression of the X-linked gene PDHA1 in four hF clones where the allelic ratio was determined by SNP-specific Taqman probes
and reported as normalised relative fluorescent units (NRFU) vs. total (allele1 + allele2). Using a known heterozygous SNP (rs1042456), clones 11
and 12 (blue diamond and circle) are shown to express a distinct allele from clones 27 and 34 (green triangle and square) while both alleles were
detected in genomic (gDNA) hF samples (dashed circle). c Heterozygous SNPs identified by RNA-seq (i.e. 379 SNPs by strategy 1 in Additional file 1:
Figure S1) are represented as red lines along the X-chromosome ideogram. Genes expressed in fibroblasts (FPKM >25th percentile) and reference genes
(USCS Genome browser) are shown in blue and black, respectively. d Density plot represents the overall allelic expression in clone 12 and 34 obtained
by RNA-seq ahead of data modelling. For each of the 379 heterozygous SNPs, the ratio between the SNP-reads overlapping allele 1 (i.e. the ones
matching the SNP reported in the Reference genome sequence) vs. the total is shown, where the intensity of grey scale represents the density of SNPs
with a certain allelic ratio. e Plot shows allelic ratios of 52 heterozygous SNPs that were identified by RNA-seq. Data represent the average of at least
two independent samples for each clone and are plotted as normalised relative fluorescent units (NRFU) of each allele vs. the total. Error bars indicate
standard errors of mean (SEM)
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looking for positions along the X chromosome at which
a different nucleotide was expressed in reciprocal clones
(Strategy 1, illustrated in Additional file 1: Figure S1).
This relies on the assumption that alleles on the Xi are
either not expressed or expressed at lower level than
their counterparts on the Xa [10]. Briefly, heterozygous
SNPs were found by mapping RNA-seq reads, identify-
ing the ‘observed base’ (i.e. the most abundant base
within the uniquely mapped reads) at each genomic
position on the X and selecting those positions at which
a different base was observed between reciprocal clones
(Additional file 1: Figure S1). We obtained a dataset
including 379 SNPs within 183 genes along the X
chromosome (Fig. 1c and Additional file 2: Table S1),
which represent approximately 25% of X-linked genes
expressed by the hFs. In total, 96% of these putative het-
erozygous SNPs were reported in the human SNP data-
base [34] and 56 SNPs were validated on genomic DNA
of both clones (using Sanger sequencing or Taqman
probes; Fig. 1e and Additional file 2: Table S1). An alter-
native strategy was also used to find heterozygous SNPs
by merging RNA-seq data from reciprocal clones to
mimic genomic DNA (Strategy 2, Additional file 1:
Figure S1), as previously reported [35]. This identified a
total of 355 SNPs, of which 354 overlapped with those
identified previously (Strategy 1) validating this dataset.
In addition, comparisons of SNP-specific expression
using RNA-seq (Fig. 1d) or Taqman (Fig. 1e) of hF
clones 12 and 34 confirmed that most X-linked genes
were transcribed only from one X chromosome and that
these clones expressed opposite haplotypes along the
entire chromosome.
To determine allele-specific expression based on genes
(rather than single SNPs) directly, we summed SNP-
specific reads within the same gene and modelled Xi
expression using a beta-binomial distribution, as previ-
ously described [36]. Briefly, data obtained from two rep-
licates of each clone were merged and the gene
probability of being inactivated (τi0, see Table 1) was
modelled based on the proportion of Xi expression
versus total, the number of Xi-specific reads and the
base quality scores within these reads. Previous studies
considered genes as expressed from the Xi based on an
empirical threshold of 10% of the Xa [10] and classified
such genes as ‘escaping XCI’ from the analysis of mosaic
cell populations with unbalanced XCI [25, 37]. Beta-
binomial modelling allowed us instead to assess the
statistical significance within our hF clones and showed
Table 1 Genes with significant Xi expression in hF clone 12 or 34
Gene Clone 12 Clone 34
Xa reads Xi reads Total reads % Xi τi0 Xa reads Xi reads Total reads % Xi τi0
ARSD 238 236 474 49.8 0 284 14 298 4.7 1.52E-06
CA5B 298 133 431 30.9 0 255 42 297 14.1 0
CDK16 4232 525 4757 11.0 0 3647 428 4075 10.5 0
CENPIa 167 6 173 3.5 0.0113 114 8 122 6.6 1.11E-05
CXorf40A 1341 3 1344 0.2 0.9975 726 191 917 20.8 0
GEMIN8 61 46 107 43.0 0 83 25 108 23.1 0
GYG2 73 31 104 29.8 0 27 0 27 0.0 0.9834
HCCSa 23 71 94 75.5 0 221 0 221 0.0 0.9951
MED14 441 34 475 7.2 0 268 15 283 5.3 1.73E-07
MXRA5 9706 97 9803 1.0 0.0194 6020 827 6847 12.1 0
PLCXD1 34 22 56 39.3 0 16 35 51 68.6 0
PNPLA4 106 19 125 15.2 0 108 2 110 1.8 0.6737
PRKX 298 2 300 0.7 0.9898 62 6 68 8.8 2.04E-05
RIBC1 18 6 24 25.0 1.73E-08 22 0 22 0.0 0.9812
RP11-1148 L6.5 835 0 835 0.0 0.9998 137 5 142 3.5 0.0153
RP11-706O15.1 564 24 588 4.1 2.18E-08 392 5 397 1.3 0.5506
SYAP1 45 16 61 26.2 0 44 6 50 12.0 6.16E-06
TMSB4X 31,358 660 32,018 2.1 4.15E-06 32,145 9 32,154 0.0 0.9873
UXT 48 26 74 35.1 0 30 33 63 52.4 0
WASH6P 13 11 24 45.8 0 12 10 22 45.5 0
XG 4868 4337 9205 47.1 0 3878 561 4439 12.6 0
aGenes with discordant XCI status in previous studies
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that approximately 15% of genes were significantly
expressed from the Xi in at least one of the two som-
atic clones examined (21 out of 145 genes with SNP-
reads ≥20 in both clones), consistent with previous
reports [10]. A good agreement was found between
our data and two previous analyses of human X
chromosome inactivation based on allelic imbalance
in human female cell lines with skewed XCI [25, 37].
As shown in Table 1, we identified 21 genes signifi-
cantly transcribed from the Xi (τi0 < 0.5) of which 16
were previously reported as escaping XCI [25, 37].
For 76 genes containing more than one SNP, we also
calculated the probability of Xi expression for each
single SNP position (Additional file 2: Table S1). This
analysis showed that more than 98% of SNPs had
concordant Xi-allelic expression within the same gene.
The few SNPs that showed discordant Xi expression
probability with others along the same gene (7 and 5
SNPs out of 328 total in clones 12 and 34, respectively)
had low Xi reads and did not change the probability of
Xi expression when summed up. Overall, these data
confirm that RNA-seq allowed robust identification of
heterozygous SNPs along the Xa and Xi and thereby to
discriminate Xi genes that expressed or silenced.
Cell-fusion between female hF clones and mESCs induces
expression of the human pluripotency network
To identify X-linked genes that were susceptible to
reactivation during the acquisition of a pluripotent state,
we then reprogrammed hF clones via cell fusion with
mESCs and performed RNA-seq at 0, 4 and 6 days after
fusion (Fig. 2a). Global RNA-seq analysis of the human-
specific reads (approximately >95% and 50% of total
reads from fibroblast and hybrid samples, respectively;
Additional file 3: Table S2) showed significant upregula-
tion of developmental genes including signalling
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Fig. 2 hF clones are reprogrammed towards an embryonic pluripotent state by fusion with mouse ESCs. a Strategy used for examining Xi-gene
reactivation during pluripotent reprograming of female hF clones. Isogenic clones with opposite XCI patterns (i.e. X1aX2i and X1iX2a) were fused
with mESCs and RNA-sequencing was performed at 0, 4 and 6 days after fusion. b Hierarchical clustering of transcription factor genes that are
part of the human pluripotency-associated gene regulatory network [43] in hESC (i.e. H9), hF clones (i.e. clone 12 and 34) and at 0, 4 and 6 days
after mESC-fusion. Displayed values correspond to the expression level (rlog, regularised logarithmic transformation) that has been scaled by the
mean expression of each gene across all samples. Expression levels were computed using RNA-seq reads that uniquely aligned to the human
reference genome, but not to mouse. Sidebars highlight major clusters and are annotated with gene ontology. Red and green bars mark genes that
are, respectively, upregulated or downregulated regulated upon cell fusion-mediated reprograming. Black bars mark clusters that are upregulated upon
cell fusion but not in hESCs, or vice versa
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pathways and cell cycle genes that specifically sustain
human pluripotency (e.g. TGF-beta, insulin/IGF and
cyclins D1-D3) [38–40] and downregulation of tissue-
specific genes including those encoding fibroblast-
associated functions (e.g. extracellular matrix organisa-
tion and cell adhesion) (Additional file 1: Figure S2A).
Furthermore, genes differentially expressed upon cell-
fusion were enriched for NANOG and OCT4 direct
targets [41] (Additional file 1: Figure S2B) consistent
with reprograming of hFs towards a pluripotent-like
state [42]. To investigate the extent of cell fusion
mediated-reprograming, we assessed the expression of
transcription factors that have been described as part of
the human embryonic stem cell (hESC)-specific gene
regulatory network by a recent systems biology approach
(i.e. CellNet, [43]). Unsupervised clustering showed that,
after fusion, hFxmESC cells had an expression profile
that is more similar to hESC (control H9) than hFs
(Fig. 2b). Interestingly, while the expression of some
pluripotency factor genes (SALL4, NANOG, PRDM14
and LIN28, lower cluster) increased at day 4 and day 6
to levels that were similar to those detected in hESCs,
other factors including OCT4 (POU5F1) were more vari-
able. Transcription of factors involved in genome organ-
isation and DNA repair appeared less abundant in
hFxmESC and hESC samples than in hF clones (Fig. 2b).
These data were consistent with cell fusion-mediated
reprograming inducing a generalised reactivation of the
human-specific pluripotency network in hF clones as
well as changes in transcriptional profile that reflect
alterations in cellular potential [32]. Of note, clustering
analysis showed that a subset of pluripotency-associated
transcription factors was induced to higher levels than
found in control hESCs (clusters highlighted by black
lines). Close inspection revealed that these genes charac-
terise naïve hESCs (Additional file 1: Figure S2C), which
are thought to resemble pluripotent cells of the human
blastocyst [44]. This suggests that cell fusion-mediated
reprograming induces a spectrum of genes that may
encompass both the naïve and the primed pluripotent
state.
X chromosome-wide analysis of allelic expression reveals
rapid reactivation of a subset of Xi genes during human
pluripotent reprograming
The extent of Xi gene reactivation induced by pluripo-
tent reprograming was examined by RNA-seq of recip-
rocal hF clones before and at 0, 4 and 6 days after fusion
with mESCs (two independent biological replicates per
clone, Fig. 3). For each sample, we considered only those
genes with 20 or more allele-specific reads in at least
one sample obtained before (i.e. hF or day 0) and after
reprograming (i.e. day 4 or day 6) and estimated the
probability that a gene is inactivated (87 genes,
Additional file 4: Table S3). Based on these results, we
classed Xi genes into three distinct categories (Fig. 3a).
We identified 16 genes that were expressed both before
and after reprograming (Fig. 3b, purple), nine genes that
showed significant Xi expression only after reprograming
(i.e. reactivated, Fig. 3c, green) and 62 genes that
remained silenced, and indeed subject to XCI, after re-
programing (Fig. 3d, red). These results highlight
substantial differences in the sensitivity of loci on the
human Xi to reprograming-mediated reactivation. To
confirm and extend this analysis, we used allele-specific
Taqman probes to determine Xi gene expression in
response to reprograming in each of the four hF clones
described previously (i.e. clones 11, 12, 27 and 34). We
observed significant re-expression upon reprograming
of many reactivation-sensitive candidate genes (6 out
of 7, Fig. 4a green) but not of reactivation-resistant
candidates (0 of 6, Fig. 4b red). Although these data
broadly confirmed the results of RNA-seq, closer
inspection revealed a surprising level of stochastic
expression among reactivation-sensitive Xi genes. In
particular, several Xi genes that appeared to be
induced upon reprograming in specific clones (e.g.
GYG2 in clone 34, 11 and 27; CTPS2 in clone 12 and
34) were already expressed in others ahead of repro-
gramming (e.g. GYG2 in clone 12, CTPS2 in clone 11
and 27). This raised the possibility that the genes dis-
playing variable Xi expression among human fibro-
blast clones might be particularly responsive to
reprograming-mediated reactivation and vice versa.
Local chromatin context and reprograming-mediated
human Xi gene reactivation
An alignment along the linear DNA sequence of the
human X chromosome revealed that most of the
reprograming-reactivated gene loci clustered on the
short Xp arm within topologically associated domains
(TADs) that are enriched for genes escaping XCI in
somatic cells (Additional file 1: Figure S3A) [45–47].
Genes neighbouring other regions prone to escape, for
example in the distal Xq arm, were not particularly sen-
sitive to reactivation upon reprograming. Furthermore,
regions adjacent to the XIST locus or close to the
centromere were not immune to reactivation, as exem-
plified by PIN4. Instead, reactivated genes appeared to
be preferentially located in evolutionarily recent regions
(strata S3–S5 illustrated in Additional file 1: Figure S3A)
that were enriched for Alu repeats and depleted of LINE
L1 elements [48, 49].
Since reprograming induced upregulation of human
pluripotency-associated factors including OCT4 and
NANOG, we asked whether the sensitivity of target
genes to reactivation might correlate with either the
extent of gene induction or the binding of such factors.
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Fig. 3 Allele-specific RNA-seq reveals differential sensitivity of Xi genes to reprograming-mediated reactivation. a Summary scheme showing the
relative positions of human Xi genes that are significantly expressed before and after reprogramming in clones 12 or 34 (purple), are reactivated
(green) or that remain inactive (red) upon reprograming; analysis based on allele-specific RNA-seq of reciprocal hF clones 12 and 34 (i.e. X1aX2i
or X1iX2a; see Fig. 1a). b–d Histogram plots show the % of minor allele (Xi) vs. total SNP-reads per gene, as assessed by RNA-seq analysis (mean ±
SEM of two biological replicates for each clone). SNPs with the lowest number of overlapping reads in hF clone 12 were considered to be Xi
alleles (and to be Xa alleles in reciprocal clone 34). Asterisks (*) mark samples showing significant expression from Xi allele in replicate merged
data (probability of inactivation τi0 < 0.05, β-binomial statistics). Complete dataset analysis is reported in Table S3
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As anticipated, reactivated genes were upregulated upon
reprograming (Additional file 1: Figure S3B, green),
while genes that remained active (purple) or inactive
(red) throughout reprogramming showed no change in
expression. Further analysis of Xa-specific and Xi-
specific reads showed that, although induction reflected
both re-expression of silent Xi alleles and increased
Xa transcription (Additional file 1: Figure S3C), these
changes were unlikely to be directly mediated by
OCT4 or NANOG as these factors bound similarly to
reactivated, active and inactive genes in hESCs
(Additional file 1: Figure S3D).
Fig. 4 Differential sensitivity of Xi genes to reprograming-mediated reactivation is validated by SNP-specific Taqman probes and extended to four
distinct hF clones. a, b Histogram plots show Xi-specific allelic expression of human X-linked genes in hFxmESC at 0, 3, 4 and 6 days after fusion.
Genes that accordingly to RNA-seq are reactivated (green) or remain inactive (red) upon reprograming or that already have significant Xi expression in
clones 12 or 34 ahead of reprogramming (purple) are shown and their locus positions are highlighted along the chromosome ideogram as vertical
lines. Allelic expression was measured by Taqman SNP-specific probes and data represented as a percentage of the Normalised Relative Fluorescence
Units (NRFU) for the Xi probe vs. the total (Xi + Xa + background in no template control). Data represent the average of at least five
independent experiments for each clone ± SEM; day 3 samples were collected only in two independent experiments. Asterisks (*) mark
significant differences vs. day 0 (p <0.05, two-sided t-test)
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To investigate whether the underlying chromatin state
influence locus susceptibility to reactivation, we analysed
H3K27me3 and H3K9me3 chromatin immunoprecipita-
tion sequencing (ChIP-seq) from published datasets of
immortalised human fibroblasts [50] (Additional file 1:
Figure S3A and E). These repressive histone modifica-
tions are preferentially enriched along distinct regions of
the Xi (Additional file 1: Figure S3A), which were previ-
ously shown to form two spatially distinct compartments
[50, 51]. Xi genes that were reactivated upon cell fusion-
mediated reprograming were preferentially localised to
H3K27me3-enriched macro-domains (Additional file 1:
Figure S3A, dashed rectangles). At the level of individual
genes, however, the average enrichment of H3K27me3
or H3K9me3 along the gene body did not show signifi-
cant differences between candidate reactivated and
inactive genes (Additional file 1: Figure S3E). As the cor-
relation between histone modifications and gene reacti-
vation might be masked where values for Xa and Xi
were combined, rather than separately assayed, we also
performed ChIP for H3K27me3 and H3K9me3 in recip-
rocal hF clones 12 and 34 and analysed the ChIP by
allele-specific probes (Additional file 1: Figure S4A and
B). This analysis of candidates occupying three distinct
TADs showed that the Xi-specific alleles of reactivated
genes generally had low H3K9me3 along the gene body,
but variable levels of H3K27me3, a profile that resem-
bled genes that were already significantly expressed from
the Xi before reprogramming, such as XG in clone12
and 34. Detailed comparisons of reactivation-sensitive
(green) and inactive loci (red) indicated that H3K27me3
and H3K9me3 levels did not however determine the
sensitivity of loci to reactivation-mediated reprograming
(Additional file 1: Figure S4C).
Human Xi genes that are susceptible to reprograming-
mediated reactivation show stochastic expression in
human fibroblasts
Reprograming assays indicate that X-linked genes have
distinct sensitivities to reactivation. In addition, the
expression of some reactivation-sensitive genes varied
considerably between different hF clones isolated from
the same female (Fig. 4a, green). To investigate the
significance of this observation we compared the allelic
expression ratios of four genes identified by RNA-seq as
reactivation-sensitive (green) with five reactivation-
resistant (red) candidates in cDNA samples from each
hF clone, where genomic DNA (gDNA) was used as an
internal control (Fig. 5a). Expression of the ‘reactivation-
sensitive’ candidates differed considerably between the
four hF clones. For example, CTPS2 was expressed at
similar levels from the Xi and Xa in clones 11 and 27
(Xi expression was approximately 50% of the total in
both genomic DNA and cDNA, arrows in Fig. 5a),
whereas in clones 12 and 34, Xi expression was signifi-
cantly lower (less than 20% of the total). Variable allelic
expression was a feature of each of the loci that showed
reactivation upon reprograming (GYG2, PRKX and
CTPS2) but not those genes that were refractory to re-
activation (TBL1X, PDHA1, MAGED2, HDAC8 and
IDS). Likewise, among a panel of 13 independently iso-
lated hF clones that originated from the same donor,
variable allelic expression was selective for the
reactivation-sensitive candidates (CTPS2 and PIN4,
Fig. 5b, green). Of note, XG that was significantly
expressed from the Xi across reprogramming in clones
12 and 34 showed instead variable Xi expression in
additional clones (Fig. 5a, purple and Additional file 2:
Table S1) and was indeed susceptible to reactivation
upon reprograming of these clones (Fig. 4b). These data
suggest genes that are sensitive to reprograming-
mediated reactivation may be stochastically expressed in
hFs. To verify this at the level of single cells rather than
clonal populations, we performed RNA-FISH to
examine mono-allelic and bi-allelic expression of
human X-linked genes in individual fibroblast nuclei.
As shown in Fig. 5c, genes such as HDAC8 and
TBLX1 that resisted reprograming-mediated reactiva-
tion, showed mono-allelic expression in the majority
(93–96% and 90–94%) of cells examined from mul-
tiple hF clones. In contrast, we observed bi-allelic
expression of the reactivation-sensitive candidate
genes WWC3 and RP11706015.1 in a proportion of
hFs (17–26% and 36–50%, respectively) with substan-
tially higher percentages in one of the four analysed
clones (i.e. clone 11). These data supported the view
that this subset of human X-linked genes is particu-
larly vulnerable to ‘stochastic’ transcription in fibro-
blasts, a property that may well reflect intrinsic
differences in mechanisms that regulate gene expres-
sion in this somatic cell type. In support of this
claim, RNA-seq analysis showed that variability in Xi
expression between isolated fibroblast clones was
common among X-linked genes identified as being
sensitive to reprograming-induced reactivation (6/9
genes with significant Xi expression in at least one
clone; τi0 ≤ 0.05) while among genes that resisted re-
activation, variability was instead rare (3/62 genes
analysed) (Additional file 5: Table S4).
Xi genes that are sensitive to DNA demethylation are
revealed through reprograming
Previous studies have shown that DNA demethylation
triggers the sporadic reactivation of Xi alleles in somatic
cells [52, 53] and is required for reprograming-induced
Xi reactivation [29, 54]. We therefore checked whether
global DNA demethylation induced by 5-deoxy-
azacytidine (5azaC; Additional file 1: Figure S5A) would
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increase Xi transcription at active, reactivated or stably
inactive genes. Although 5azaC treatment was able to
significantly increase Xi expression ahead of reprogram-
ing (from 18% to 28%) at XG locus in clone 34
(Additional file 1: Figure S5B), we did not observe sig-
nificant changes in Xi expression at any of the candidate
reactivation-sensitive (GYG2, PRKX, CTPS2, FUNDC1,
PIN4 and SRPX2) or reactivation-resistant genes
(TBL1X, PDHA1, APOO, MAGED2, HDAC8 and IDS)
tested. This suggested that DNA methylation was
unlikely to be the cause of the stochastic Xi re-
expression in hF clones.
As both DNA demethylation and XIST loss were sug-
gested to be required for X chromosome reactivation in
mouse [54, 55], we reasoned that 5azaC might enhance
reactivation upon reprograming. We therefore treated
hF clones for three days before mESC-fusion and ana-
lysed Xi-specific expression in hFxmESC cells at 0, 4
Fig. 5 Variable allelic expression of Xi genes in hFs predicts their susceptibility to reprograming-mediated reactivation. a Histograms show
Xi-allelic expression (as a percentage of total) of 10 X-linked genes in hF clones 11 and 12 and reciprocal clones 27 and 34 (grey), where
gDNA provides controls. Allelic expression was measured using Taqman probes as NRFU of the Xi-specific probe vs. the total; data for each hF clone
represent the average of at least three independent cultures. Arrows indicate significant differences in Xi expression (p <0.05, two-sided t-test) as
compared with data from other clones. Genes that accordingly to RNA-seq are stably expressed (purple), reactivated (green) or remain inactive (red)
across reprograming in clones 12 or 34 are shown. b Xi-allelic expression of CTPS2, PIN4 (reactivated genes), MAGED2 and IDS (inactive) in 13 additional
hF clones. Analysis was performed as in (a). Asterisk (*) marks clones with Xi expression significantly different from the others (p <0.05, Grubbs test).
c Mono-allelic and bi-allelic expression of X-linked genes in hFs was determined using RNA-FISH (exemplified in the images shown to the right) where
punctate signals (red, arrowed) represent transcribed X-linked gene loci. At least 200 nuclei containing either a single punctate signal (mono-allelic) or
two separate signals (bi-allelic) were scored for each hF clone and the percentage of total cells showing mono-allelic or bi-allelic (in brackets) patterns
is shown. For HDAC8 and TBL1X >90% of the analysed cells showed mono-allelic expression. # indicates samples with higher bi-allelic expression than
others (RNA-FISH) where significant Xi expression was also detected (RNA-seq). DAPI (blue) stains nuclei and scale bars indicate 5 μm
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and 6 days as outlined in Fig. 6a. Xi expression of reacti-
vated genes was induced at similar levels and with the
same kinetics as in the absence of 5azaC (Fig. 6b, green),
consistent with the susceptibility of these genes to
reactivation being independent of DNA methylation.
However, a different subset of genes was consistently
reactivated upon 5azaC pre-treatment and cell fusion-
mediated reprograming (Fig. 6b, yellow) including
Fig. 6 DNA demethylation induces Xi reactivation upon reprograming at loci within high H3K9me3 and low H3K27me3 domains. a Scheme
illustrates the experimental outline. hF clones were cultured in the presence of 5-azaC for three days before fusion with mESCs. 5-azaC was
removed from cultures at fusion and allelic expression of X-linked genes was analysed 0, 4 and 6 days post fusion. b Histogram plots show
Xi-allelic expression during reprograming upon 5azaC pre-treatment. Inactive alleles with a significant Xi induction upon 5azaC pre-treatment and
cell fusion-mediated reprograming are shown in orange, whereas refractory alleles are shown in red. Asterisks (*) mark significant changes vs. day
0 (p ≤0.05, two-sided t-test). Allelic expression was measured by Taqman probes as NRFU of the Xi-specific probe versus the total. Data represent
the average of two independent experiments ± SEM for each clone. c Box plots show Xi-specific enrichment of H3K9me3 and H3K27me3 in clones
12 and 34. Xi enrichment has been detected by using SNP-specific Taqman probes and normalising Ct values to H3 ChIP and input DNA. ChIP
was performed in at least two independent experiments for each clone
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candidates such as TBLX1 and HDAC8 that had previ-
ously resisted reactivation. Longer 5azaC treatment pro-
vided moderate increases in Xi-expression levels upon
reprograming (Additional file 1: Figure S5C). As several
genes were refractory to 5azaC-reprograming-mediated
reactivation in one hF clone but induced in another
(PDHA1, MAGED2 and HDAC8 in clones 12 vs. 34,
Fig. 6b) we asked whether this reflected differences in
underlying H3K27me3 or H3K9me3 levels. Among the
candidates examined, sensitivity to 5azaC pre-treatment
correlated with high levels of H3K9me3 and low levels
of H3K27me3 (orange), as compared with genes previ-
ously characterised as active (purple), reactivated (green)
or that were refractory to reactivation across reprogram-
ing (red, Fig. 6c).
Our results show that loci along the human X chromo-
some have distinct susceptibilities to reprograming-
mediated reactivation that reflects both their genomic
context and the local chromatin environment that is resi-
dent (or induced) within somatic cells. Among the 87
human X genes sampled here, we have identified nine that
are reactivated upon reprograming (10%) and 62 that
remain inactive (71%). Seven genes within the inactive
cohort (11%) were shown to be DNA methylation-
sensitive. In addition, genes identified as being particularly
prone to reprograming-mediated XCR also showed
evidence of variable Xi expression within individual hFs
and hF clones, suggesting that these two processes are
mechanistically related.
Discussion
Our study set out to examine human X chromosome
reactivation directly during pluripotent reprograming of
somatic cells using allele-specific RNA-seq approaches.
We have examined 87 X-linked genes and provide the
first direct and quantitative evidence of Xi transcription
in several hF clones before, and immediately after, the
induction of pluripotency. Previous iPS studies have gen-
erally used indirect measures of XCR, such as X:auto-
some expression ratios [28, 56] or loss of DNA
methylation [29, 57], to gauge Xi gene expression. Here,
we have instead used allele-specific RNA-seq to discrim-
inate transcripts originating from the Xa and Xi and to
directly quantify their expression during reprograming.
We have applied statistical modelling to directly assess
significant Xi expression rather than relying on empirical
definitions of XCI escape as being greater than 10% of
Xa expression. Recent studies in mouse cells and tissues
have shown that allele-specific RNA-seq detects a wider
range of Xi expression and allows genes that escape XCI
to be estimated with a higher level of sensitivity than
previous techniques [14, 36]. Using a similar approach,
we show selective reactivation of genes along the human
Xi upon induction of the human pluripotency network.
Due to the epigenetic instability of the Xi in human
pluripotent cells [27, 58], and differences in the repro-
graming routes of iPSC versus cell–cell fusions, direct
comparisons between different approaches is problem-
atic. However, one of the genes described in our analysis,
GYG2, has been shown to reactivate during early iPSC
reprograming [59]. Recent reports also show that Xi
genes that are reactivated at early iPSC stages can
undergo subsequent de novo inactivation, probably due
to inappropriate culture conditions [59, 60]. Interest-
ingly, some genes that have been shown to be reacti-
vated at late iPSC stages, including PDHA1 and IDS, are
reactivated by cell fusion-mediated reprograming after
5azaC pre-treatment of somatic clones. This suggests
that fusion with mESCs promotes a different (and poten-
tially faster) reprograming route than iPSCs and sup-
ports claims that DNA demethylation is required for the
reactivation of a subset of human Xi genes during pluri-
potent reprograming [29].
From our RNA-seq analysis, we estimate that Xi
reactivation occurs in about 10% of human X-linked
genes. This selectivity could reflect the mechanism by
which silencing is propagated along the X chromosome
and, therefore, underlying genetic and epigenetic differ-
ences. It was originally proposed that silencing spreads
linearly from the XIST locus into adjacent and more dis-
tal DNA, aided by specific repetitive sequences [61].
However, recent studies in mouse showed that Xist RNA
first binds to loci that are in close spatial proximity to its
locus [8, 9] and then propagates to inactivated genes,
suggesting that ‘spatial’ spreading may underpin XCI.
Here, we show that reactivation of genes along the
human Xi is not limited to telomeric regions distal to
the XIST locus, as previously suggested [28]. We observe
instead that several reactivated genes localise within
TADs enriched of genes constitutively escaping XCI (i.e.
GYG2, PRKX, RP11-706O15.1 and CTPS2). Recent stud-
ies showed that chromatin domains along the Xa and Xi
have a distinct spatial organisation [62] with TAD-like
structures that retain DNA accessibility being present
along the Xi only around genes escaping XCI [47]. As
loci of escaping Xi genes have been shown to interact
within each other [63] spatially segregating from in-
active loci [64, 65], our data support the hypothesis
that three-dimensional chromatin organisation might
influence gene susceptibility to expression. Interest-
ingly, reprograming-reactivated genes within the same
TAD of loci that remained inactive were enriched in
SINEs and depleted in L1 LINEs, confirming that
repeat sequences also contribute to the spread of
silencing along the X chromosome [20].
Since two spatially distinct heterochromatin compart-
ments can be distinguished along the human Xi based
on the preferential enrichment of H3K9me3 or
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H3K27me3 [50, 51], we also investigated whether these
chromatin features influence the predisposition of genes
to reactivation. Analysis of published ChIP-seq data
showed that reactivated genes preferentially localised
within macro-domains enriched in H3K27me3 and de-
pleted in H3K9me3 (dashed squares in Additional file 1:
Figure S3A). Allele-specific ChIP analysis in our hF
clones also confirmed that Xi loci of reactivated genes
have low levels of H3K9me3 ahead of reprograming,
consistent with previous reports that H3K9me3 can act
as a barrier for reprograming [66, 67]. Interestingly, a
recent study has shown that XIST RNA mainly associ-
ates with H3K27me3-enriched domains in hFs, whereas
the heterochromatin protein HP1α co-localises with
H3K9me3 domains [50]. Furthermore, loss of XIST RNA
in hESC lines that have already undergone XCI leads to
the reactivation of genes within H3K27me3 domains [58].
Collectively, these data suggest that silencing of distinct
loci along the human Xi might be maintained by partially
overlapping XIST-dependent and XIST-independent
mechanisms, and that genes within H3K27me3 domains
(and depleted in H3K9me3) might be more susceptible to
reactivation in a pluripotent cellular environment.
Consistent with this hypothesis, in a recent study we have
shown that the delocalisation of XIST RNA and loss of
H3K27me3 from the Xi are early events that precede
partial Xi reactivation during cell fusion-mediated repro-
graming [68]. Interestingly, we show here that a second
set of genes become susceptible to reprograming-
mediated reactivation following DNA demethylation.
These genes show high H3K9me3 and low H3K27me3
levels, suggesting that DNA methylation might be differ-
entially regulated across the human Xi through proteins
such as SMCHD1 that can bind H3K9me3 domains and
mediate DNA methylation [69, 70].
Perhaps the most surprising result from our study is the
finding that Xi gene reactivation can be predicted from
detailed transcript analysis in single cell-derived clones
ahead of reprograming. Evidence that human Xi genes
that are sensitive to reprograming-mediated reactivation
show stochastic Xi expression in hFs was derived both
from RNA-seq analysis of hF clones and from single-cell
RNA-FISH studies. It seems unlikely that stochastic ex-
pression reflects escape from either DNA methylation or
facultative heterochromatin because these genes had simi-
lar levels of H3K27me3 and H3K9me3 in expressing and
non-expressing clones, and 5azaC treatment was not able
to induce Xi expression. Treatment with 5azaC did, how-
ever, reveal the reactivation of a different subset of Xi
genes upon reprograming.
Conclusions
Overall, these results have two important implications.
First, they suggest that multiple different modes of
silencing exist along the human Xi. Silencing of
reprograming-reactivated genes might depend on the in-
trinsic expression probability of the gene and rely on
stochastic transcriptional events that are stabilised upon
pluripotent conversion. Consistent with this hypothesis,
we noted that increases in the expression of X-
reactivated genes upon cell fusion-mediated reprogram-
ing originated from both the Xa and Xi. Interestingly,
stochasticity has been proposed to regulate Xi expres-
sion across the regions of the human X chromosome
that have been most recently added during evolution
(i.e. XAR) [22] and where most of the reprograming-
reactivated candidate genes lie. Distinct Xi regions might
instead be silenced by multiple epigenetic modifications
that need to be erased to permit reactivation. This was
highlighted by the discovery of a second cohort of Xi
genes that were reactivated only after DNA demethyla-
tion. Second, our data suggest that Xi genes that will be
successfully reactivated following pluripotent reprogram-
ing can be reliably predicted ahead of fusion by compar-
ing allelic expression patterns in somatic cell clones.
This result underscores the importance of understanding
the underlying causes of intrinsic transcriptional vari-
ability and mosaicism that occur in normal female tis-
sues. It also raises the interesting possibility that cell
types showing maximal Xi-allelic variation might be the
most suitable targets for human iPSC reprograming
where reactivation of the X chromosome is desired.
Given the high incidence of disease-associated genes res-
iding on the X chromosome [71, 72], investigating XCI
in single cells and their clonal derivatives may help to
better design rational strategies to achieve locus-specific
or domain-specific Xi reactivation.
Methods
Cell culture and fusion
Human fibroblasts NHDF17914 (Lonza) were immorta-
lised with pBABE-hTERT-blast and single-cell clones were
derived in 3% O2. In order to confirm the expression of a
single X chromosome, clones were screened by PDHA1
and ATRX RFLP analysis as previously described [33].
Mouse ESCs E14Tg2a HPRT-/ were transfected with
pCAG-puro [73] to derive a stable clonal line.
For fusion experiments, cells were mixed in 1:1 ratio
and treated in suspension with poly-ethylene-glycol
(PEG 1500, Roche), as previously described [32]. Briefly,
for RNA-seq experiments, 7 × 107 hFs were harvested
and fused to an equal number of mESCs by adding
2 mL of 50% PEG and stirring at 37 °C for 90 s. PEG
was subsequently diluted with 4 volumes of KO-DMEM,
resuspended in mESC medium (KO-DMEM supple-
mented with 10% FCS, 1% non-essential amino acids,
2 mM L-glutamine, 50 μM β-mercaptoethanol and
10 μg/mL penicillin/streptomycin) and plated onto
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gelatinised dishes at a density of 106 cells per 140 mm
dish. Heterokaryons and hybrids were cultured at 3% O2
in mESC media supplemented with LIF and selected
after 12 h by adding puromycin (1.5 μg/mL) and HAT
(20 μM hypoxantine, 0.08 mM aminopterin and 3.2 mM
thymidine; Sigma). At each timepoint, 105 cells were col-
lected for RNA extraction. All experiments have been
performed with hF clones between passages 8 and 14.
Allele-specific Taqman PCR
Taqman PCR was performed with Taqman Universal
Master Mix No AmpEraseUNG (Applied Biosystems) on
RNAse-H treated single-strand cDNA (First Strand
Synthesis kit, Invitrogen) or genomic DNA. Allele-
specific Taqman probes (Applied Biosystem) were used
for the analysis.
RNA-sequencing
Total RNA was extracted using RNABee (Amsbio) and
treated with 0.5 units/μg of DNAseI (Turbo DNAse kit;
Ambion) to degrade traces of gDNA. Complete removal
of gDNA contamination was tested by PCR amplifica-
tion of total RNA and only samples with no amplicon
upon 40 PCR cycles were processed. Libraries were pre-
pared from 0.6 μg of total RNA (RIN >7.5) by True-seq
RNA sample prep v2 kit (Illumina) and were amplified
by 13 PCR cycles. Paired-end 100 bp reads were gener-
ated using HiSeq2500 sequencer (Illumina). GEO access
number: GSE60308.
Heterozygous SNP identification from RNA-seq
To identify heterozygous SNPs along the X chromo-
somes of NHDF17914 cells, we sequenced RNA libraries
obtained from two clones with reciprocal XCI patterns
(Strategy 1, Additional file 1: Figure S1). We mapped
RNA-seq reads obtained from two biological replicates
of each clone to the Human genome (hg19) using
Tophat v2.0.8/Bowtie 2.1.0 [74, 75]. Biological replicates
were merged following alignment. For each clone, we
used SAMtools mpileup and BCFtools to separately
identify the observed base (i.e. the most abundant base)
and its phred scaled quality score at every genomic pos-
ition along the X chromosome. We considered only
positions with a minimum of eight overlapping reads
and phred scaled quality score ≥20 in both clones. The
positions at which a different base was identified as the
most abundant in reciprocal clones were selected as
putative heterozygous SNPs. We annotated the SNPs
using Annovar [76], discarded SNPs overlapping more
than one gene and retained only the SNPs within
mature transcript regions (i.e. exons and UTR). The
final dataset is composed of 379 heterozygous SNPs
across 183 genes. Full list of the SNPs is reported in
Additional file 2: Table S1.
An alternative/independent approach (Strategy2 in
Additional file 1: Figure S1) was used to validate the
identified SNPs. This second approach is based on the
different assumption that gene expression levels will be
almost equivalent in the two clones thus mirroring gen-
omic ratios. Briefly, SAMtools was used for directly
identifying heterozygosity (Hardy-Weinberg equilibrium
hypothesis) from merged clone 12 and clone 34 align-
ments. This second strategy found 355 heterozygous
SNPs out of which 354 were in common with previous
analysis, thus showing the robustness of our approach.
Human-specific alignments and allelic expression analysis
of X-linked genes
RNA-seq was performed on hF clone 12 and 34 before
and at 0, 4 and 6 days after mESC fusion in two inde-
pendent fusion experiments per clone. To analyse the
human-specific transcripts, RNA-seq reads were aligned
independently to human (hg19, Ensembl gene version
72) and mouse reference genome (mm9, Ensembl gene
version 67) using Tophat v2.0.8 and the reads aligning to
both human and mouse genomes were excluded from
further analysis. The number of SNP-overlapping reads
for each allele was obtained using SAMtools mpileup.
In order to reconstruct the haplotypes of the two X
chromosomes, at each SNP position the base with the
highest read depth in hF clone 12 was considered as the
Xa allele in this clone and the Xi one in clone 34. The
Xa and Xi alleles were considered the same for all the
samples in a time series.
To calculate allelic expression, we summed up the
reads overlapping the Xa or the Xi alleles at the different
SNPs along the same gene and excluded SNP positions
overlapping two or more gene transcripts.
We used a beta-binomial model to assess the XCI sta-
tus quantitatively and estimate the probability that a
gene is inactivated. The beta-binomial distribution has
been previously used to model differences in allelic ex-
pression [77] and estimate XCI [36, 78] by taking into
account read count information (e.g. nucleotide variation
and base sequencing quality) and overcoming the over
dispersion of RNA-seq data. For each gene, we mod-
elled the probability of inactivation as previously de-
scribed [36]. Briefly, we estimated the total number of
Xi-specific reads, the sum of base quality scores
within these reads and the Xi ratio versus total; we
fitted these data to a mixture of two beta-binomial
distributions, one accounting for genes subject to in-
activation and one for genes expressed from the Xi.
When observing a probability of inactivation (τi0)
<0.05 we considered a gene significantly expressed
from the Xi with 95% confidence.
In order to distinguish between genes that are reacti-
vated (green) and the ones that are already active ahead
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of reprogramming (purple) or remain subject to XCI (red)
across reprograming, we separately estimated the prob-
ability of inactivation (τi0, see Additional file 4: Table S3)
in hF and at 0, 4 and 6 days after mESC-fusion. To
increase confidence in annotation, only genes with mini-
mum 20 SNP-overlapping reads (in hF or day0 and in
day4 and day6) were considered (87 genes) and classified
as follows: ‘reactivated’ genes, which are not expressed
from the Xi (τi0 > 0.05) in hF/day0 but acquire signifi-
cant Xi expression (τi0 ≤ 0.05) at one data-point of the
time series in at least one clone after reprograming
(green); ‘active’ genes, which have significant Xi ex-
pression (τi0 ≤ 0.05) in hF/day0 before reprograming
and at one data-point of the timeseries after repro-
graming in at least one clone (purple); ‘inactive’
genes, which are not significantly expressed from the
Xi (τi0 > 0.05) in hF and all data-points of the time
series in both clones (red). Genes with less than 20
SNP-overlapping reads across the time series were
not evaluated.
Data obtained from two independent biological
replicates for each clone were either merged by sum-
ming up Xi and Xa SNP-specific reads and their base
quality scores (Additional file 4: Table S3) or
analysed separately. Single replicates showed a good
concordance both for Xi expression ratios (mean ±
standard error is shown Fig. 3) and for beta-binomial
statistics (concordance between replicates for SNPs
with more than 10 overlapping reads was of 98%,
99%, 95% and 97% in clone 12 for hF, days 0, 4 and
6 respectively; and 94%, 97% and 89% in clone 34 for
hF, days 0 and 4, respectively) with variations mainly
due to different sequencing depth among replicates
and not affecting the final classification compared to
merged data.
Gene expression analysis
We counted the reads overlapping with genes using
HTseq and identified the differentially expressed genes
using edgeR [79]. FPKM values were estimated using R
script.
Reproducibility between independent biological repli-
cates (i.e. separate fusion experiments), or between dis-
tinct clones, was assessed by Spearman correlation
analysis using FPKMs and R script. Correlation coeffi-
cients (r) comparing gene expression between independ-
ent replicates were higher than 0.90 and 0.87 in clones
12 and 34, respectively. The same comparison between
clones 12 and 34 gave r values ≥ 0.88 for all timepoints.
RNA-FISH analysis and probes
Probes used for RNA-FISH analysis were obtained by
nick translation of appropriate phosmids/BACs con-
taining HDAC8, TBLX1, CTPS2 and RP11-706O15.1
(i.e. RP11-1021B19, RP11-451G24, CTD-2277I2 and WI2-
1543 K8, respectively), in the presence of fluorophore-
coupled dUTPs as previously described [80]. Locus-
specific transcriptional signals were detected in hF
nuclei and scored according to the detection of a
single focus, of two separate foci (>1 microns apart)
or >2 signals per nucleus [68]. More than 200 cells
were scored in each sample.
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